F-star Therapeutics, Inc. Quarterly Liabilities and Equity in USD from Q4 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
F-star Therapeutics, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Liabilities and Equity for the quarter ending September 30, 2022 was $83.7M, a 27.1% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $83.7M -$31.1M -27.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $101M -$24.3M -19.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $115M +$61.3M +115% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $123M +$59.4M +93.4% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $115M +$87.6M +321% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $125M +$93.9M +302% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $53.4M -$2.09M -3.76% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $63.6M +$25.1M +65.3% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $27.2M -$42.9M -61.2% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $31.1M -$26M -45.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $55.5M -$8.83M -13.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $38.5M -$30.3M -44.1% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $70.2M -$4.87M -6.49% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $57.1M +$14.1M +32.7% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $64.4M +$15.2M +31% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $68.8M +$16.5M +31.5% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $75.1M +$21.2M +39.4% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $43M -$14.8M -25.7% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $49.1M +$26.9M +121% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $52.3M +$25.5M +94.7% Dec 31, 2017 10-K 2019-03-11
Q3 2017 $53.8M +$36.6M +212% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $57.8M +$36.7M +173% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $22.2M +$11.4M +106% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $26.9M +$12.3M +84.4% Dec 31, 2016 10-K 2018-02-20
Q3 2016 $17.2M Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $21.2M Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $10.8M Mar 31, 2016 10-Q 2016-06-15
Q4 2015 $14.6M Dec 31, 2015 10-K 2017-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.